Search for the latest oncology news by tumour type
A combination of the experimental histone deacetylase (HDAC) inhibitor entinostat with the anti-PD-1 therapeutic pembrolizumab…
The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumour activity with durable responses in patients…
Vaccination with as few as four tumour antigens generated antigen-specific responses, reduced intestinal tumours, and…
Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center found preliminary evidence that…
Melanomas tend to be ‘hot’ or ‘cold’ – if they’re hot, immunotherapy lights melanoma tumours…
Switching pancreatic cancer patients to the PARP inhibitor rucaparib as maintenance therapy instead of continuing…
Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk…
Prostate cancer incidence and mortality rates are decreasing or stabilising in most parts of the…
The experimental oncolytic adenovirus telomelysin (OBP-301) in combination with radiotherapy was safe and showed early…
Surgery was associated with higher survival rates for patients with HER2-positive (HER2 ) stage 4…